←
LukeGilbert51 posts
LukeGilbert avatar

LukeGilbert

@LukeGilbertSF

Core Investigator at Arc Institute and Associate Professor at UCSF

◷ Joined May 2019
LukeGilbert avatar
LukeGilbert@LukeGilbertSF·Sep 8

Cells mitigate damage to DNA in surprising ways. Using a series of CRISPRi chemogenomics screens, we identified a PRDX1-dependent iron–damage axis in the DNA damage response. Congratulations to Tom, Abe, Shaheen, Josep and all co-authors! doi.org/10.1038/s41589-026-0…

LukeGilbert avatar
LukeGilbert@LukeGilbertSF·Aug 21

Interested in predictive modeling for biology? Check out Arc's 2026 Virtual Cell Challenge!

The 2026 Virtual Cell Challenge has begun! Submissions and the leaderboard are now open. This year's task: multi-context generalization and zero-shot prediction. Models will need to predict perturbation responses in cellular contexts with no Challenge-specific training data. arcinstitute.org/news/virtua…

LukeGilbert avatar
LukeGilbert@LukeGilbertSF·Apr 16

I never thought we would be working on Vitamin E but unbiased CRISPR screens take you into unexpected biology. I am delighted to present our work on how mTORC1 activity suppresses ferroptosis through a SCARB1-dependent HDL-Vitamin E uptake pathway. Congratulations to Tom and all co-authors! Paper: sciencedirect.com/science/ar…

LukeGilbert avatar
LukeGilbert@LukeGilbertSF·Feb 19

We mapped gene interactions across different environmental conditions (GxGxE) at scale for the first time in human cells. These maps lead to the realization that many genes function in a context dependent manner which provides insight into how humans have relatively few genes but many cell types. Congratulations Ben! Paper: cell.com/molecular-cell/full…

LukeGilbert avatar
LukeGilbert@LukeGilbertSF·Jan 28

I am so excited to see epigenetic editing (CRISPRoff) move forward as a new approach in medicine through this clinical trial. We hope to make a difference for folks with HBV. Congratulations on a big step forward to all who made this possible! nchromabio.com/press-release…

LukeGilbert avatar
LukeGilbert@LukeGilbertSF·18 Nov 2025

Invested in high content CRISPR screening and predictive models? Come to Perturb2026 (March 18/19 2026 in Vienna)! I am co-organizing this conference and am greatly looking forward to what promises to be a fantastic meeting. perturb2026.bio/

LukeGilbert avatar
LukeGilbert@LukeGilbertSF·5 Nov 2025

Too many men die of prostate cancer. We miss you John. We discovered a new way of attacking androgen receptor driven prostate cancers that will lead to new therapeutics. This was a wonderful collaboration with @li_haolong and Felix Feng (rest in peace). doi.org/10.1038/s41588-025-0…

Arc Institute avatar
⟳ LukeGilbert retweeted
Arc Institute@arcinstitute·5 Nov 2025

A study out today in @NatureGenet from Core Investigator @LukeGilbertSF, @li_haolong & others identifies PTGES3 as a critical regulator of androgen receptor (AR) protein levels in prostate cancer, revealing a potential new target for tumors that become treatment-resistant.

Post attachment
Arc Institute avatar
⟳ LukeGilbert retweeted
Arc Institute@arcinstitute·21 Oct 2025

Published today in @NatureBiotech, @LaineGoudy. @LukeGilbertSF, Alex Marson, and colleagues report a new epigenetic editing platform that safely reprograms multiple genes in human T cells without many of the challenges & risks associated with traditional gene editing approaches.

Post attachment